ASAP Act

This bill would add tests that screen for early-stage Alzheimer's disease and related dementias to the services Medicare covers. Covered tests would be those given on or after January 1, 2028, that are cleared or approved by the Food and Drug Administration. The tests would include genomic sequencing blood tests and other tests the Secretary of Health and Human Services decides give comparable results, such as other blood, urine, tissue, or imaging-based tests. Medicare would pay for these tests under the same payment system it uses for clinical lab tests.

Full text and official record on Congress.gov

Sponsors

• Susan M. Collins Republican sponsor
• 57 cosponsors